David Shaw’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PTCT
David Shaw's PTCT Position: Q3 2026 in Review
David Shaw reduced its PTC Therapeutics (PTCT) stake by 60% in Q3 2026, selling an estimated $67.7M and leaving 618,723 shares worth $40.1M. The position accounts for 0.02% of the portfolio, ranked #887.
David Shaw first reported a position in PTCT in Q2 2014 and has held it in 46 quarters since. The position peaked at $133M in Q3 2025. 361 funds tracked by Wall St. Rank hold PTCT as of Q3 2026.
- David Shaw held 618,723 shares of PTC Therapeutics worth $40.1M as of Q3 2026.
- David Shaw sold 930,196 PTC Therapeutics shares in Q3 2026, an estimated $67.7M.
- PTC Therapeutics made up 0.02% of David Shaw's portfolio in Q3 2026, its #887 holding.
- David Shaw first reported a position in PTC Therapeutics in Q2 2014 and has held it in 46 quarters since.
- David Shaw's PTC Therapeutics position peaked at $133M in Q3 2025.
- 361 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2026.
Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.